HIV/AIDS Transmission
Improving perceived self-efficacy reduces HIV transmission behaviors
Published in AIDS Weekly, June 21st, 2004
"This study examined the impact of changes in self-efficacy over time on HIV-related injection and sex risk behaviors among Puerto Rican drug injectors and crack smokers. Baseline (T1) and 6-month follow-up (T2) data were collected between 1998 and 2000 in New York and Puerto Rico (follow-up rate = 79%, 952/1199)," reported investigators in the journal Addictive Behaviors.
"Differences in scores on self-efficacy (for risk behaviors) between T1 and T2 were first computed and dichotomized (negative change versus no/positive change). Those with negative change in self-efficacy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-06-21)
More Articles from AIDS Weekly
- HIV/AIDS
Ezrin/CD95 linkage key role regulating susceptibility to CD95-mediated apoptosis - HIV/AIDS
Intracellularly expressed HIV-1 Tat protein inhibits neural cell proliferation - HIV/AIDS Progression
Timed ablation of regulatory CD4+ T cells prevents AIDS progression - HIV/AIDS Treatment
Cell surface targets identified for HIV-1 therapeutics using genetic screens - Virology
Dendritic cell-associated function impairment distinguish HCV and HIV infection - AIDS Vaccine
Volunteers needed as more AIDS vaccines move into clinical trials - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
